APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycoside Antibiotics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aminoglycoside Antibiotics Industry Growth and Trends Forecast to 2032

Report ID 173962820126 December 202597 pages

Choose your research edition.

Industry ResearchAminoglycoside Antibiotics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycoside Antibiotics Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Aminoglycoside Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycoside Antibiotics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycoside Antibiotics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Aminoglycoside Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aminoglycoside Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aminoglycoside Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aminoglycoside Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aminoglycoside Antibiotics include Merck, Novartis Pharmaceuticals, Medson Pharmaceuticals, Kremoint Pharma, Britannica and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aminoglycoside Antibiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aminoglycoside Antibiotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aminoglycoside Antibiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aminoglycoside Antibiotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aminoglycoside Antibiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aminoglycoside Antibiotics Market by Company

Merck

Novartis Pharmaceuticals

Medson Pharmaceuticals

Kremoint Pharma

Britannica

Allergan

Aminoglycoside Antibiotics Segment by Type

Neomycin

Tobramycin

Gentamicin

Paromomycin

Kanamycin

Amikacin

Aminoglycoside Antibiotics Segment by Application

Neonatal Sepsis

Veterinary

UTI & Pelvic Disease

Respiratory

Aminoglycoside Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycoside Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycoside Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycoside Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aminoglycoside Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aminoglycoside Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Neomycin Table 2. Major Company of Tobramycin Table 3. Major Company of Gentamicin Table 4. Major Company of Paromomycin Table 5. Major Company of Kanamycin Table 6. Major Company of Amikacin Table 7. Global Aminoglycoside Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 9. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Type (2021-2026) Table 10. Global Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 11. Global Aminoglycoside Antibiotics Sales Market Share in Value by Type (2021-2026) Table 12. Global Aminoglycoside Antibiotics Price by Type (2021-2026) & (US$/Unit) Table 13. Global Aminoglycoside Antibiotics Sales by Type (2027-2032) & (K Units) Table 14. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Type (2027-2032) Table 15. Global Aminoglycoside Antibiotics Sales by Type (2027-2032) & (US$ Million) Table 16. Global Aminoglycoside Antibiotics Sales Market Share in Value by Type (2027-2032) Table 17. Global Aminoglycoside Antibiotics Price by Type (2027-2032) & (US$/Unit) Table 18. North America Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 19. North America Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 21. Europe Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 25. Latin America Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Aminoglycoside Antibiotics Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Aminoglycoside Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 28. Aminoglycoside Antibiotics Industry Trends Table 29. Aminoglycoside Antibiotics Industry Drivers Table 30. Aminoglycoside Antibiotics Industry Opportunities and Challenges Table 31. Aminoglycoside Antibiotics Industry Restraints Table 32. Global Aminoglycoside Antibiotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Aminoglycoside Antibiotics Revenue Market Share by Company (2021-2026) Table 34. Global Aminoglycoside Antibiotics Sales by Company (2021-2026) & (K Units) Table 35. Global Aminoglycoside Antibiotics Sales Share by Company (2021-2026) Table 36. Global Aminoglycoside Antibiotics Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Aminoglycoside Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Aminoglycoside Antibiotics Major Company Production Sites and Headquarters Table 39. Global Aminoglycoside Antibiotics Company, Product Type & Application Table 40. Global Aminoglycoside Antibiotics Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Aminoglycoside Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Aminoglycoside Antibiotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Aminoglycoside Antibiotics Sales by Region (2021-2026) & (K Units) Table 45. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Region (2021-2026) Table 46. Global Aminoglycoside Antibiotics Sales by Region (2021-2026) & (US$ Million) Table 47. Global Aminoglycoside Antibiotics Sales Market Share in Value by Region (2021-2026) Table 48. Global Aminoglycoside Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Aminoglycoside Antibiotics Sales by Region (2027-2032) & (K Units) Table 50. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Region (2027-2032) Table 51. Global Aminoglycoside Antibiotics Sales by Region (2027-2032) & (US$ Million) Table 52. Global Aminoglycoside Antibiotics Sales Market Share in Value by Region (2027-2032) Table 53. Global Aminoglycoside Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Aminoglycoside Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 56. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Application (2021-2026) Table 57. Global Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 58. Global Aminoglycoside Antibiotics Sales Market Share in Value by Application (2021-2026) Table 59. Global Aminoglycoside Antibiotics Price by Application (2021-2026) & (US$/Unit) Table 60. Global Aminoglycoside Antibiotics Sales by Application (2027-2032) & (K Units) Table 61. Global Aminoglycoside Antibiotics Sales Market Share in Volume by Application (2027-2032) Table 62. Global Aminoglycoside Antibiotics Sales by Application (2027-2032) & (US$ Million) Table 63. Global Aminoglycoside Antibiotics Sales Market Share in Value by Application (2027-2032) Table 64. Global Aminoglycoside Antibiotics Price by Application (2027-2032) & (US$/Unit) Table 65. North America Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 66. North America Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 68. Europe Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 72. Latin America Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Aminoglycoside Antibiotics Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Aminoglycoside Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Aminoglycoside Antibiotics Product Portfolio Table 79. Merck Recent Development Table 80. Novartis Pharmaceuticals Company Information Table 81. Novartis Pharmaceuticals Business Overview Table 82. Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Novartis Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio Table 84. Novartis Pharmaceuticals Recent Development Table 85. Medson Pharmaceuticals Company Information Table 86. Medson Pharmaceuticals Business Overview Table 87. Medson Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Medson Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio Table 89. Medson Pharmaceuticals Recent Development Table 90. Kremoint Pharma Company Information Table 91. Kremoint Pharma Business Overview Table 92. Kremoint Pharma Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Kremoint Pharma Aminoglycoside Antibiotics Product Portfolio Table 94. Kremoint Pharma Recent Development Table 95. Britannica Company Information Table 96. Britannica Business Overview Table 97. Britannica Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Britannica Aminoglycoside Antibiotics Product Portfolio Table 99. Britannica Recent Development Table 100. Allergan Company Information Table 101. Allergan Business Overview Table 102. Allergan Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Allergan Aminoglycoside Antibiotics Product Portfolio Table 104. Allergan Recent Development Table 105. North America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 106. North America Aminoglycoside Antibiotics Sales by Country (2021-2026) & (K Units) Table 107. North America Aminoglycoside Antibiotics Sales Market Share by Country (2021-2026) Table 108. North America Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 109. North America Aminoglycoside Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 110. North America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. North America Aminoglycoside Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 112. North America Aminoglycoside Antibiotics Market Share by Country (2021-2026) Table 113. North America Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. North America Aminoglycoside Antibiotics Market Share Forecast by Country (2027-2032) Table 115. Europe Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. Europe Aminoglycoside Antibiotics Sales by Country (2021-2026) & (K Units) Table 117. Europe Aminoglycoside Antibiotics Sales Market Share by Country (2021-2026) Table 118. Europe Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 119. Europe Aminoglycoside Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 120. Europe Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Europe Aminoglycoside Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 122. Europe Aminoglycoside Antibiotics Market Share by Country (2021-2026) Table 123. Europe Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Europe Aminoglycoside Antibiotics Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Aminoglycoside Antibiotics Sales by Country (2021-2026) & (K Units) Table 127. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share by Country (2021-2026) Table 128. Asia-Pacific Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 129. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Aminoglycoside Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 132. Asia-Pacific Aminoglycoside Antibiotics Market Share by Country (2021-2026) Table 133. Asia-Pacific Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Asia-Pacific Aminoglycoside Antibiotics Market Share Forecast by Country (2027-2032) Table 135. Latin America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Latin America Aminoglycoside Antibiotics Sales by Country (2021-2026) & (K Units) Table 137. Latin America Aminoglycoside Antibiotics Sales Market Share by Country (2021-2026) Table 138. Latin America Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 139. Latin America Aminoglycoside Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 140. Latin America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Latin America Aminoglycoside Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 142. Latin America Aminoglycoside Antibiotics Market Share by Country (2021-2026) Table 143. Latin America Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Latin America Aminoglycoside Antibiotics Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Aminoglycoside Antibiotics Sales by Country (2021-2026) & (K Units) Table 147. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share by Country (2021-2026) Table 148. Middle East and Africa Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 149. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Aminoglycoside Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 152. Middle East and Africa Aminoglycoside Antibiotics Market Share by Country (2021-2026) Table 153. Middle East and Africa Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Middle East and Africa Aminoglycoside Antibiotics Market Share Forecast by Country (2027-2032) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Aminoglycoside Antibiotics Distributors List Table 158. Aminoglycoside Antibiotics Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Aminoglycoside Antibiotics Image Figure 2. Global Aminoglycoside Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aminoglycoside Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Aminoglycoside Antibiotics Sales (2021-2032) & (K Units) Figure 5. Neomycin Image Figure 6. Global Neomycin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tobramycin Image Figure 8. Global Tobramycin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Gentamicin Image Figure 10. Global Gentamicin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Paromomycin Image Figure 12. Global Paromomycin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Kanamycin Image Figure 14. Global Kanamycin Sales YoY Growth (2021-2032) & (K Units) Figure 15. Amikacin Image Figure 16. Global Amikacin Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Aminoglycoside Antibiotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Aminoglycoside Antibiotics Market Share by Type 2025 VS 2032 Figure 19. North America Aminoglycoside Antibiotics Sales Market Share in Volume by Type in 2025 Figure 20. North America Aminoglycoside Antibiotics Sales Market Share in Value by Type in 2025 Figure 21. Europe Aminoglycoside Antibiotics Sales Market Share in Volume by Type in 2025 Figure 22. Europe Aminoglycoside Antibiotics Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share in Value by Type in 2025 Figure 25. Latin America Aminoglycoside Antibiotics Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Aminoglycoside Antibiotics Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Aminoglycoside Antibiotics Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Neonatal Sepsis Image Figure 32. Global Neonatal Sepsis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Veterinary Image Figure 34. Global Veterinary Sales YoY Growth (2021-2032) & (K Units) Figure 35. UTI & Pelvic Disease Image Figure 36. Global UTI & Pelvic Disease Sales YoY Growth (2021-2032) & (K Units) Figure 37. Respiratory Image Figure 38. Global Respiratory Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Aminoglycoside Antibiotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Aminoglycoside Antibiotics Market Share by Application 2025 VS 2032 Figure 41. North America Aminoglycoside Antibiotics Sales Market Share in Volume by Application in 2025 Figure 42. North America Aminoglycoside Antibiotics Sales Market Share in Value by Application in 2025 Figure 43. Europe Aminoglycoside Antibiotics Sales Market Share in Volume by Application in 2025 Figure 44. Europe Aminoglycoside Antibiotics Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Aminoglycoside Antibiotics Sales Market Share in Value by Application in 2025 Figure 47. Latin America Aminoglycoside Antibiotics Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Aminoglycoside Antibiotics Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share in Value by Application in 2025 Figure 51. North America Aminoglycoside Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Aminoglycoside Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Aminoglycoside Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Aminoglycoside Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Aminoglycoside Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Aminoglycoside Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Aminoglycoside Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Aminoglycoside Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Aminoglycoside Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Aminoglycoside Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Aminoglycoside Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Aminoglycoside Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Aminoglycoside Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Aminoglycoside Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Aminoglycoside Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Aminoglycoside Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Aminoglycoside Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Aminoglycoside Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Aminoglycoside Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Aminoglycoside Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Aminoglycoside Antibiotics Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Aminoglycoside Antibiotics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Paromomycin
  • Kanamycin
  • Amikacin
Applications
  • Neonatal Sepsis
  • Veterinary
  • UTI & Pelvic Disease
  • Respiratory
Companies covered
  • Merck
  • Novartis Pharmaceuticals
  • Medson Pharmaceuticals
  • Kremoint Pharma
  • Britannica
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aminoglycoside Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aminoglycoside Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aminoglycoside Antibiotics Market by Type
  6. 1.3.1 Neomycin
  7. 1.3.2 Tobramycin
  8. 1.3.3 Gentamicin
  9. 1.3.4 Paromomycin
  10. 1.3.5 Kanamycin
  11. 1.3.6 Amikacin
  12. 1.4 Global Aminoglycoside Antibiotics Market Size by Type
  13. 1.4.1 Global Aminoglycoside Antibiotics Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Aminoglycoside Antibiotics Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Aminoglycoside Antibiotics Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Aminoglycoside Antibiotics Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Aminoglycoside Antibiotics Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Aminoglycoside Antibiotics Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Aminoglycoside Antibiotics Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Aminoglycoside Antibiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aminoglycoside Antibiotics Industry Trends
  2. 2.2 Aminoglycoside Antibiotics Industry Drivers
  3. 2.3 Aminoglycoside Antibiotics Industry Opportunities and Challenges
  4. 2.4 Aminoglycoside Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aminoglycoside Antibiotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Aminoglycoside Antibiotics Sales (2021-2026)
  3. 3.3 Global Top Players by Aminoglycoside Antibiotics Price (2021-2026)
  4. 3.4 Global Aminoglycoside Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aminoglycoside Antibiotics Major Company Production Sites & Headquarters
  6. 3.6 Global Aminoglycoside Antibiotics Company, Product Type & Application
  7. 3.7 Global Aminoglycoside Antibiotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aminoglycoside Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aminoglycoside Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aminoglycoside Antibiotics Tier 1, Tier 2, and Tier 3
4 Aminoglycoside Antibiotics Regional Status and Outlook
  1. 4.1 Global Aminoglycoside Antibiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aminoglycoside Antibiotics Historic Market Size by Region
  3. 4.2.1 Global Aminoglycoside Antibiotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aminoglycoside Antibiotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aminoglycoside Antibiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aminoglycoside Antibiotics Forecasted Market Size by Region
  7. 4.3.1 Global Aminoglycoside Antibiotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aminoglycoside Antibiotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aminoglycoside Antibiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aminoglycoside Antibiotics by Application
  1. 5.1 Aminoglycoside Antibiotics Market by Application
  2. 5.1.1 Neonatal Sepsis
  3. 5.1.2 Veterinary
  4. 5.1.3 UTI & Pelvic Disease
  5. 5.1.4 Respiratory
  6. 5.2 Global Aminoglycoside Antibiotics Market Size by Application
  7. 5.2.1 Global Aminoglycoside Antibiotics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Aminoglycoside Antibiotics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Aminoglycoside Antibiotics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Aminoglycoside Antibiotics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Aminoglycoside Antibiotics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Aminoglycoside Antibiotics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Aminoglycoside Antibiotics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Aminoglycoside Antibiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Aminoglycoside Antibiotics Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Novartis Pharmaceuticals
  8. 6.2.1 Novartis Pharmaceuticals Company Information
  9. 6.2.2 Novartis Pharmaceuticals Business Overview
  10. 6.2.3 Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio
  12. 6.2.5 Novartis Pharmaceuticals Recent Developments
  13. 6.3 Medson Pharmaceuticals
  14. 6.3.1 Medson Pharmaceuticals Company Information
  15. 6.3.2 Medson Pharmaceuticals Business Overview
  16. 6.3.3 Medson Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medson Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio
  18. 6.3.5 Medson Pharmaceuticals Recent Developments
  19. 6.4 Kremoint Pharma
  20. 6.4.1 Kremoint Pharma Company Information
  21. 6.4.2 Kremoint Pharma Business Overview
  22. 6.4.3 Kremoint Pharma Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kremoint Pharma Aminoglycoside Antibiotics Product Portfolio
  24. 6.4.5 Kremoint Pharma Recent Developments
  25. 6.5 Britannica
  26. 6.5.1 Britannica Company Information
  27. 6.5.2 Britannica Business Overview
  28. 6.5.3 Britannica Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Britannica Aminoglycoside Antibiotics Product Portfolio
  30. 6.5.5 Britannica Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Aminoglycoside Antibiotics Product Portfolio
  36. 6.6.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Aminoglycoside Antibiotics Sales by Country
  2. 7.1.1 North America Aminoglycoside Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aminoglycoside Antibiotics Sales by Country (2021-2026)
  4. 7.1.3 North America Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aminoglycoside Antibiotics Market Size by Country
  6. 7.2.1 North America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aminoglycoside Antibiotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aminoglycoside Antibiotics Sales by Country
  2. 8.1.1 Europe Aminoglycoside Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aminoglycoside Antibiotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aminoglycoside Antibiotics Market Size by Country
  6. 8.2.1 Europe Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aminoglycoside Antibiotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aminoglycoside Antibiotics Sales by Country
  2. 9.1.1 Asia-Pacific Aminoglycoside Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aminoglycoside Antibiotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aminoglycoside Antibiotics Market Size by Country
  6. 9.2.1 Asia-Pacific Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aminoglycoside Antibiotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aminoglycoside Antibiotics Sales by Country
  2. 10.1.1 South America Aminoglycoside Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aminoglycoside Antibiotics Sales by Country (2021-2026)
  4. 10.1.3 South America Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aminoglycoside Antibiotics Market Size by Country
  6. 10.2.1 South America Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aminoglycoside Antibiotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aminoglycoside Antibiotics Sales by Country
  2. 11.1.1 Middle East and Africa Aminoglycoside Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aminoglycoside Antibiotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aminoglycoside Antibiotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aminoglycoside Antibiotics Market Size by Country
  6. 11.2.1 Middle East and Africa Aminoglycoside Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aminoglycoside Antibiotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aminoglycoside Antibiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aminoglycoside Antibiotics Value Chain Analysis
  2. 12.1.1 Aminoglycoside Antibiotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aminoglycoside Antibiotics Production Mode & Process
  7. 12.2 Aminoglycoside Antibiotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aminoglycoside Antibiotics Distributors
  10. 12.2.3 Aminoglycoside Antibiotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst